Carolina Speech Pathology Announces Bedside FEES Service for Washington State During Washington Health Care …

Carolina Speech Pathology Announces Bedside FEES Service for Washington State During Washington Health Care Association Conference

Dysphagia is a term used to describe swallowing disorders. The exact prevalence of dysphagia is unknown; there are suggestions that it can be as high as 22% in those over 50 years of age. Approximately 10 million American are evaluated each year with swallowing difficulties. Those difficulties negatively impact quality of life and impaired swallowing can cause significant morbidity and mortality (ASHA.org). More specifically to patients in Skilled Nursing Facilities the prevalence of dysphagia can range from 30-75%. Those patients require addition care and are often on highly restrictive and expensive diets.

"Carolina Speech Pathology is proud of our continuous growth and looks forward to sharing our 16 years of experience with dysphagia to help improve the lives of patients in Washington. Our bedside FEES will provide significant cost savings to care facilities and improve patient outcomes while also creating a better quality of life. By reducing the need for transportation to the hospital for more cumbersome and expensive MBS procedures, our procedure creates a winning scenario that benefits the patient, the facility and the established rehab department," said Randy Aguero, CSP Business Development Director.

Carolina Speech Pathology is based in Apex, North Carolina. The announced expansion to WA adds to their coverage area of VA, NC, SC, GA , FL, AL, WV, CA and OR, and partner coverage in IN, OH, TN and KY. CSP is known for hiring experienced Speech-Language Pathologists and responding to FEES study requests within 3-5 business days.

Read this article:
Carolina Speech Pathology Announces Bedside FEES Service for Washington State During Washington Health Care ...

Elk and nutrition

Lack of good, summer nutrition may be one reason elk are spending more time on private Wallowa Valley and Zumwalt Prairie land and not in the national forest. KATY NESBITT / The Observer

Researchers John and Rachel Cook conduct ground-breaking work

Decreases in elk herd numbers have prompted agencies and biologists alike to look to their habitat for clues.

A series of studies, started in 1995, reveal a new piece to the puzzle: the importance of nutritionto elk health, reproduction and survival.

While working with a large herd of tame elk in the early 90s,La Grande researchers John and Rachel Cook of the National Council for Air and Stream Improvement started questioning the importance of nutrition.

Nutrition is an important mechanism of the animals performance that was understudied at the time we started our research, said John Cook.

Cook said recruitment of calves until adult age classes has declined by about half since the 1950s across the Blue Mountains. With this in mind, the Cooks set out to discover if nutrition is indeed a factor, if so, whats causing the problems, and to come up with solutions.

Elk are one the most studied wildlife species in the western United States, but the Cooks nutrition research was ground-breaking. The fact that elk herds were declining across the Northwest, said Cook, tended to shift the focus away from habitat quality, thermal cover, and roads, to understanding what it is about habitat thatdrives population dynamics and performance.

The Cooks have used both wild and tame elk for nearly two decades to learn about their nutritional needs. What they discovered is that a small difference in nutrition has a big effect on performance.

The tame elk study started with 60 elk, all around the age of 4 or 5 years old. They were divided into three groups to determine the effects of nutrition on reproduction.

Continue reading here:
Elk and nutrition

Seegene and DuPont Nutrition & Health Agree to Develop Highly Multiplexed Molecular Assays for Food Safety Testing

WILMINGTON, DE and SEOUL, SOUTH KOREA--(Marketwire -05/24/12)- Seegene Inc. (096530.KQ), a leading developer of multiplex molecular technologies and diagnostic tests, and DuPont Nutrition & Health, a leading provider of rapid, molecular diagnostic systems, have agreed to jointly develop new, highly multiplexed assays for the detection of foodborne pathogens.

Combining novel technologies from Seegene with the powerful chemistry and analytics of the BAX System from DuPont allows for a potential step-change in pathogen testing. For example, Seegene DPO technology generates consistently high specificity by eliminating primer competition, and TOCE technology allows the identification of multiple targets in a single dye channel. With this agreement, DuPont and Seegene are seeking to develop highly multiplexed, real-time PCR assays that provide for rapid detection and differentiation of 10 or more organisms from a single sample in a single test.

"We are constantly seeking innovative collaborators to develop science-based solutions that will meet evolving needs for food safety and quality," said George Tice, research and development director, DuPont Qualicon Diagnostics. "This integration of unique Seegene technologies with robust diagnostic systems from DuPont will give the food industry increasingly powerful tools to help protect their products and their brands."

"Working with DuPont Qualicon Diagnostics opens a significant new market opportunity for our portfolio of multiplex molecular technologies," said Jong-Yoon Chun, founder and CEO of Seegene. "By leveraging these novel technologies, we can advance from the current 'one test, one pathogen' approach to a 'one test, many pathogens' paradigm. This will significantly improve the efficiency and effectiveness of food safety testing, and help to reduce the prevalence of foodborne illness."

This initiative marks the entry of Seegene's multiplex technologies into the multi-billion dollar food safety testing market. According to The Centers for Disease Control and Prevention, foodborne illness each year in the United States alone affects 48 million people.

DPO technology is a fundamental tool for blocking extension of non-specifically primed templates, generating assays that are both highly specific and highly sensitive. TOCE enables simultaneous multiplex testing, by using the differences in melting temperatures of designed artificial amplicons. Prior to TOCE, multiplex assays were difficult because even a small variation in amplicon sequences changes the melting temperature (Tm) of the amplicon. TOCE technology overcomes current limitations of Tm analysis and allows testing of multiple targets with one fluorescent label by ensuring that sequence variation does not change the melting temperature.

Food processing companies around the world rely on the BAX system from DuPont Qualicon Diagnostics to detect pathogens or other organisms in raw ingredients, finished products and environmental samples. The automated system uses leading-edge technology, including polymerase chain reaction (PCR) assays, tableted reagents and optimized media to detect Salmonella, Listeria species, Listeria monocytogenes, E. coli O157:H7 and STEC, Cronobacter, Campylobacter, Staphylococcus aureus, Vibrio, and yeast and mold. With certifications and regulatory approvals in the Americas, Asia and Europe, the BAX system is one of the most advanced pathogen testing system available to food companies. For more information, please visit http://www.qualicon.com

Seegene is the world's leading developer of multiplex molecular technologies and multiplex clinical molecular diagnostics (M-MoDx). Seegene's core enabling technologies -- ACP, DPO, READ, and TOCE -- are the foundation for M-MoDx tests that can simultaneously detect multiple targets with high sensitivity, specificity and reproducibility. Seegene's products detect multi-pathogens with great reliability and throughput, ultimately providing the most economical basis for saving time, labor and cost. Seegene's mission is to maintain leadership in molecular diagnostics for infectious diseases, genetics, pharmacogenetics, and oncology using innovative proprietary technologies. For more information please visit http://www.seegene.com or call +301-762-9066.

The DuPont Nutrition & Health division addresses the world's challenges in food by offering a wide range of sustainable, bio-based ingredients and advanced microbial diagnostic solutions to provide safer, healthier and more nutritious food. Through close collaboration with customers, DuPont combines knowledge and experience with a passion for innovation to deliver unparalleled customer value to the marketplace.

DuPont (DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com and http://www.qualicon.com.

Read this article:
Seegene and DuPont Nutrition & Health Agree to Develop Highly Multiplexed Molecular Assays for Food Safety Testing

Nutrition Experts Convene to Discuss New Patient Malnutrition Research

Canadian Malnutrition Task Force Emphasizes an Unrecognized Public Health Issue in our Canadian Hospitals

VANCOUVER, May 24, 2012 /CNW/ - Today and tomorrow at the Canadian Nutrition Society's annual meeting in Vancouver, The Canadian Malnutrition Task Force (CMTF) is presenting preliminary results of the Nutrition Care in Canadian Hospitals Study underscoring that in the hospital setting, malnutrition is prevalent and that nutritional status deteriorates in many patients and that this may affect clinical outcomes. Nutritional care needs to be improved to promote the recovery process. The Task Force is comprised of concerned healthcare professionals and researchers, looking to address the malnutrition issues in Canadian Hospitals.

CMTF strives to achieve optimal nutritional status for adult and paediatric patients in hospitals and older adults living in the community and in long term care (LTC) facilities, by developing and promoting valid nutrition care processes as part of standard clinical care. Malnutrition is a widespread Canadian issue that requires the public's attention to close the gaps between research and practice in the prevention, detection and treatment of malnutrition in Canadians through the continuum of care.

Previous research studies confirm that optimal nutrition is a significant problem in Canada.

"CMTF is now conducting a new study assessing the issue of malnutrition and nutrition care in Canadian hospitals across the country. This is an important study because patient recovery depends not only on specific disease treatments but it also depends on adequate nutrition. Unfortunately, the role of nutrition care is often not well recognized across our health care system," says Dr. Heather Keller, Professor, Department of Kinesiology, University of Waterloo and Co-Chair of the Canadian Malnutrition Task Force.

This new study, the Nutrition Care in Canadian Hospitals Study, includes locations across the country to assess nutritional status and prevalence of malnutrition, evaluate the practice of nutritional care, identify potential tools to improve the situation, as well as outline the physical, psychological and economic impact of malnutrition and poor nutrition care.

According to preliminary results, the prevalence of malnutrition is about 40 per cent in our Canadian hospitals, with the severely malnourished patients being older with more co-morbidities. Results also suggest that nutritional status deteriorates for some in hospital and malnourished patients have higher mortality. Nutritional status at admission predicts a shorter length of stay, as does eating more than 50 per cent of meals provided and being younger than 60 years of age. This indicates that we need to put more effort into maintaining and improving nutritional status and food intake in hospitalized patients to promote a faster recovery.

It is also important to note that based on this study, physicians don't consistently assess patient nutritional status at admission and discharge and that although most patients were satisfied with food quality, half of them ate less than 50 per cent of their meals for various reasons. A patient satisfaction survey, which was part of the study, identified that patients have challenges with the size of serving portions, being able to reach their meal trays, opening packages and even missing meals for medical procedures.

PRELIMINARY STUDY FINDINGS FOR PATIENT SATISFACTION

The Task Force will continue to finalize the study to garner important insights that will improve the malnutrition situation for countless Canadian patients. Data collection began in August 2010 with the anticipated completion of the study toward the end of the fall 2012.

Original post:
Nutrition Experts Convene to Discuss New Patient Malnutrition Research

Dr. Karen Lloyd receives WHOI’s Holger W. Jannasch Visiting Scholar Award

Public release date: 25-May-2012 [ | E-mail | Share ]

Contact: WHOI Media Relations Office media@whoi.edu 508-289-3340 Woods Hole Oceanographic Institution

The Woods Hole Oceanographic Institution (WHOI) has chosen Karen Lloyd, an assistant professor in the Department of Microbiology at the University of Tennessee in Knoxville, as the recipient of the Holger W. Jannasch Visiting Scholar Award.

The award recognizes Lloyd for her "outstanding contributions to the field of marine microbiology," as well as her demonstrated excellence in mentoring students and commitment to educational public outreach.

Lloyd is currently pushing the frontiers of the field by analyzing the diversity and function of yet-to-be cultivated bacteria and archaeaa group of single-celled microorganismsin deep subseafloor sediments using single-cell genomics and other cutting-edge techniques. Her research focuses on linking uncultivated microorganisms to their geochemical functions and exploring how these communities react to changing environmental conditions.

Lloyd will visit WHOI the week of July 9-13, 2012, and present two lectures to students and scientists in the Woods Hole community. The first talk, on a general scientific topic, will be Monday, July 9, 2012, at 3 p.m. in Redfield Auditorium. Lloyd will present a second talk, which will focus on her research, Wednesday, July 11, 2012, at noon in Clark 507.

"This is a wonderful opportunity to recognize a talented young microbiologist while celebrating the legacy of Holger Jannasch, who shaped the field of marine microbiology," said WHOI Biology Department Chair Mark Hahn.

The visiting scholar award is named in memory of Jannasch, a WHOI senior scientist in the Biology Department and world-renowned, deep-sea microbiologist, who died in 1998. During his illustrious career, he isolated and cultivated many microbes, studied their physiology and adaptations to the environment, and explored associations between microbes and animals. He also was involved in designing sophisticated instrumentation for collecting and culturing bacteria, as well as to measure rates of microbial activity in the deep-sea. Jannasch and his WHOI colleagues performed pioneering work investigating microbial decomposition rates in the deep sea.

Following the discovery of deep-sea hydrothermal vents in the late 1970s, Jannasch's lab again played an instrumental role in identifying chemosynthesis as the nutritional basis for life at deep-sea vents, which has had major implications for deep-sea microbial ecology and the way we think about the origin of life on Earth.

"My first exposure to oceanography was working as a lab technician at WHOI for Andreas TeskeHolger Jannasch's successora year after Dr. Jannasch's passing. His work influenced nearly every aspect of the field of deep sea microbiology, and I am honored to receive the award that bears his name," Lloyd said.

Visit link:
Dr. Karen Lloyd receives WHOI's Holger W. Jannasch Visiting Scholar Award

The American Society for Microbiology announces the 2012 Award Laureates

Public release date: 24-May-2012 [ | E-mail | Share ]

Contact: Garth Hogan ghogan@asmusa.org American Society for Microbiology

The American Society for Microbiology (ASM) is proud to announce the 2012 award laureates. The awards will be presented during the 112th General Meeting of the ASM, June 16-19, 2012 in San Francisco, CA.

Abbott Award in Clinical and Diagnostic Immunology honors a distinguished scientist in the field of clinical or diagnostic immunology. Bruce S. Rabin, M.D., Ph.D., Medical Director, Clinical Immunopathology, University of Pittsburgh Medical Center, PA

Abbott-ASM Lifetime Achievement Award honors an individual whose made sustained contributions to the microbiological sciences. Stuart B. Levy, M.D., Director, Center for Adaptation Genetics and Drug Resistance, Distinguished Professor of Medicine, Tufts University School of Medicine, Boston, MA

ASM Founders Distinguished Service Award recognizes a member of ASM for outstanding contributions to the Society in a volunteer capacity at the national level. Ellen Jo Baron, Ph.D., Director, Medical Affairs, Cepheid, Sunnyvale, CA

ASM Graduate Microbiology Teaching Award honors an individual for exemplary teaching of microbiology and mentoring of students at the graduate and postgraduate levels and for encouraging students to subsequent achievement. Joanna B. Goldberg, Ph.D., Professor, University of Virginia, Charlottesville

BD Award for Research in Clinical Microbiology honors a distinguished clinical microbiologist for outstanding research accomplishments leading to or forming the foundation for important applications in clinical microbiology. Patrice Courvalin, M.D., Head of the Antibacterial Agents Unit, Insitut Pasteur, Paris, France

bioMrieux Sonnenwirth Award for Leadership in Clinical Microbiology recognizes a distinguished microbiologist for the promotion of innovation in clinical laboratory science, dedication to ASM, and the advancement of clinical microbiology as a profession. Susan E. Sharp, M.S., Ph.D., Director of Microbiology, Kaiser Permanente Northwest, Portland, OR

Carski Foundation Distinguished Undergraduate Teaching Award recognizes a mature individual for distinguished teaching of microbiology to undergraduate students and for encouraging them to subsequent achievement. Lilliam Casillas-Martinez, Ph.D., Full Professor, University of Puerto Rico, Humacao

See the original post here:
The American Society for Microbiology announces the 2012 Award Laureates

Top 8 Longevity/Sillage to beat skin chemistry PLUS Baudelaire by Bayredo Giveaway! – Video

24-05-2012 12:29 These 8 will beat your perfume eating skin into submission and last hour after hour after hour, they also smell great! Also I'm trying to offload a bottle of Baudelaire by high-end hytniche brand Bayredo, so if your subscribe to my channel and drop a message in the comments section below you could be the lucky recipient of an boxed 50ml bottle! Bottega Veneta by Bottega Veneta -

More here:
Top 8 Longevity/Sillage to beat skin chemistry PLUS Baudelaire by Bayredo Giveaway! - Video

'Personality genes' may help account for longevity

ScienceDaily (May 24, 2012) "It's in their genes" is a common refrain from scientists when asked about factors that allow centenarians to reach age 100 and beyond. Up until now, research has focused on genetic variations that offer a physiological advantage such as high levels of HDL ("good") cholesterol. But researchers at Albert Einstein College of Medicine and Ferkauf Graduate School of Psychology of Yeshiva University have found that personality traits like being outgoing, optimistic, easygoing, and enjoying laughter as well as staying engaged in activities may also be part of the longevity genes mix.

The findings, published online May 21 in the journal Aging, come from Einstein's Longevity Genes Project, which includes over 500 Ashkenazi Jews over the age of 95, and 700 of their offspring. Ashkenazi (Eastern European) Jews were selected because they are genetically homogeneous, making it easier to spot genetic differences within the study population.

Previous studies have indicated that personality arises from underlying genetic mechanisms that may directly affect health. The present study of 243 of the centenarians (average age 97.6 years, 75 percent women) was aimed at detecting genetically-based personality characteristics by developing a brief measure (the Personality Outlook Profile Scale, or POPS) of personality in centenarians.

"When I started working with centenarians, I thought we'd find that they survived so long in part because they were mean and ornery," said Nir Barzilai, M.D., the Ingeborg and Ira Leon Rennert Chair of Aging Research, director of Einstein's Institute for Aging Research and co-corresponding author of the study. "But when we assessed the personalities of these 243 centenarians, we found qualities that clearly reflect a positive attitude towards life. Most were outgoing, optimistic and easygoing. They considered laughter an important part of life and had a large social network. They expressed emotions openly rather than bottling them up." In addition, the centenarians had lower scores for displaying neurotic personality and higher scores for being conscientious compared with a representative sample of the U.S. population.

"Some evidence indicates that personality can change between the ages of 70 and 100, so we don't know whether our centenarians have maintained their personality traits across their entire lifespans," continued Dr. Barzilai. "Nevertheless, our findings suggest that centenarians share particular personality traits and that genetically-based aspects of personality may play an important role in achieving both good health and exceptional longevity."

The study is titled "Positive attitude towards life and emotional expression as personality phenotypes for centenarians." The POPS was developed by lead author Kaori Kato, Psy.D., now at Weill Cornell Medical College, who validated it through comparisons with two previously established measures of personality traits. Other authors of the study were Richard Zweig, Ph.D., assistant clinical professor of psychiatry and behavioral sciences at Einstein and director of the Older Adult Program at Ferkauf, and Gil Atzmon, Ph.D., assistant professor of medicine and of genetics at Einstein.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

Story Source:

The above story is reprinted from materials provided by Albert Einstein College of Medicine.

See the original post here:
'Personality genes' may help account for longevity

Longevity, efficiency key themes to new shop, storage building

MARION Longevity and efficiency are the key themes for an equipment shop and storage building that was built near here.

The 81x168-foot building, built by Jim Lensch, is 18 feet tall. The shop area is 68 feet long, and the cold storage area is 100 feet long.

The longevity started with a good foundation.

Ron Mormann, builder with Mormann Contracting and Supply, says if you look at some of the older barns that are still standing, they have a good foundation, such as rock or concrete.

Coming up from the foundation, the building has manufactured sand flooring in the cold-storage area, explains Lensch.

The sand flooring is soft in case someone has to be on the floor to get under equipment, says the East Central Iowa farmer.

In the shop, the floor is 8-inch-thick concrete with a zoned radiant floor-heating system with 2 inches of foam. A drain was put in the shop area that was designed for power washing farm equipment.

The interior shop walls are fiberglass-reinforced panels. The panels have the insulation value of R-33, notes Mark Mooberry, a district sales manager with EPS Buildings in Osage.

Mooberry says his company is seeing more interest from farmers for more panel buildings. They also want more concrete foundations to add to the strength and longevity of their equipment buildings.

Lensch says he wanted stainless-steel fasteners to be used on exterior and interior walls to prevent rust.

Original post:
Longevity, efficiency key themes to new shop, storage building

DARPA’s Synthetic Army

DARPA, the science arm of the US Department of Defense, is trying to find a way to create a streamlined manufacturing process for purpose-specific engineering of plants and animals, reports Popular Science's Rebecca Boyle. This program, called Living Foundries, "sets up an assembly line paradigm for life and its constituent parts," Boyle says. "Under this program, genetic engineering would no longer be limited to modification of existing organisms instead, scientists would be able to concoct anything they wanted from scratch, using a suite of ingredients and processes that could apply in any situation." And DARPA's first grants for the program have just been announced $15.5 million spread among six institutions and companies, including the J. Craig Venter Institute. This last pick is particularly appropriate, she says, given the group's work in synthetic biology.

The purpose of the grants is to build a basic library of modularized parts that can be used in assembling various organisms, Boyle says, like wires or circuits that can be used to build electronics. "The ultimate goal is a genetic starter set that could be snapped together like so many Legos, forming any system the military might require," she adds.

Our sister publication GenomeWeb Daily News has more on the project here.

Read more:
DARPA's Synthetic Army

Researchers develop new genetic method to pinpoint individuals’ geographic origin

Public release date: 23-May-2012 [ | E-mail | Share ]

Contact: Wileen Wong Kromhout wwkromhout@support.ucla.edu 310-206-0540 University of California - Los Angeles

Understanding the genetic diversity within and between populations has important implications for studies of human disease and evolution. This includes identifying associations between genetic variants and disease, detecting genomic regions that have undergone positive selection and highlighting interesting aspects of human population history.

Now, a team of researchers from the UCLA Henry Samueli School of Engineering and Applied Science, UCLA's Department of Ecology and Evolutionary Biology and Israel's Tel Aviv University has developed an innovative approach to the study of genetic diversity called spatial ancestry analysis (SPA), which allows for the modeling of genetic variation in two- or three-dimensional space.

Their study is published online this week in the journal Nature Genetics.

With SPA, researchers can model the spatial distribution of each genetic variant by assigning a genetic variant's frequency as a continuous function in geographic space. By doing this, they show that the explicit modeling of the genetic variant frequency the proportion of individuals who carry a specific variant allows individuals to be localized on a world map on the basis of their genetic information alone.

"If we know from where each individual in our study originated, what we observe is that some variation is more common in one part of the world and less common in another part of the world," said Eleazar Eskin, an associate professor of computer science at UCLA Engineering. "How common these variants are in a specific location changes gradually as the location changes.

"In this study, we think of the frequency of variation as being defined by a specific location. This gives us a different way to think about populations, which are usually thought of as being discrete. Instead, we think about the variant frequencies changing in different locations. If you think about a person's ancestry, it is no longer about being from a specific population but instead, each person's ancestry is defined by the location they're from. Now ancestry is a continuum."

The team reports the development of a simple probabilistic model for the spatial structure of genetic variation, with which they model how the frequency of each genetic variant changes as a function of the location of the individual in geographic space (where the gene frequency is actually a function of the x and y coordinates of an individual on a map).

"If the location of an individual is unknown, our model can actually infer geographic origins for each individual using only their genetic data with surprising accuracy," said Wen-Yun Yang, a UCLA computer science graduate student.

Read more from the original source:
Researchers develop new genetic method to pinpoint individuals' geographic origin

Clemens’s DNA Was on Syringe, Cotton Balls, Witness Says

By Tom Schoenberg - 2012-05-25T16:42:02Z

Roger Clemenss genetic material was found on medical waste that his former trainer turned over to federal investigators, a DNA analyst testified at the perjury trial of the ex-New York Yankees pitcher.

Alan Keel of Forensic Science Associates, a California consulting firm, told federal court jurors today in Washington that he found Clemenss DNA on two cotton balls and a syringe. The former trainer, Brian McNamee, left blood on a piece of gauze and pus on a piece of tissue, Keel said. McNamee said earlier he might have cut himself breaking the top of an ampul.

The amount of Clemenss DNA found on the syringe was about six to 12 cells, Keel said.

A very small amount of biological material was recovered, he said.

Keel, a prosecution witness, agreed with Assistant U.S. Attorney Courtney Saleski that a small amount is not unusual for an intramuscular injection.

Clemens, a seven-time Cy Young Award winner, is charged with one count of obstructing a congressional investigation, three counts of making false statements and two counts of perjury stemming from his testimony to a House panel investigating the use of performance-enhancing drugs including steroids and human growth hormone.

The ballplayer faces as long as 21 months in prison if convicted. He denies having used the drugs. The government is trying to prove he used them and lied about it to Congress.

The prosecutions evidence includes the needle and cotton with Clemenss DNA that tested positive for anabolic steroids, prosecutors said. The material came from McNamee, who said he saved needles, gauze and vials from one of the injections in 2001. He told jurors he kept some of the items in a Miller Lite beer can that he took from the recycling bin in Clemenss apartment.

McNamee has testified that he gave the ballplayer injections of steroids and HGH during the 1998, 2000 and 2001 baseball seasons while both men worked for the Toronto Blue Jays and the Yankees.

Visit link:
Clemens’s DNA Was on Syringe, Cotton Balls, Witness Says

Posted in DNA

Expert says DNA on medical waste allegedly saved after steroids injection matched Clemens'

WASHINGTON A forensic scientist testified Friday that two cotton balls and a syringe needle allegedly saved after a steroids injection tested positive for Roger Clemens' DNA, a key moment as the government tries to prove the former pitcher used performance-enhancing drugs.

Alan Keel told jurors that the DNA on both cotton ball matches were "unique to one person who has ever lived on the planet" Clemens. He said that one of the cotton balls had a random match possibility of one in 15.4 trillion for Clemens' DNA, and the other had one in 173 trillion, when comparing to the population of white people in the U.S.

The needle was not as conclusive, because Keel was only able to get a handful of cells. That match was one in 449.

Brian McNamee, Clemens' former strength coach, earlier testified he collected the medical waste after injecting the pitcher with steroids in 2001, and turned them over to federal authorities in 2008. Earlier government witnesses testified that steroids were found on the medical waste.

Clemens is accused of lying to Congress in 2008 when he denied using performance-enhancing drugs.

Prosecutors hope that Clemens' DNA which helped make him one of the most successful pitchers in baseball history will help them convict him of a federal crime.

While Keel's testimony was a milestone moment for the government, the defense indicated early on it wouldn't contest that the needle had both steroids and Clemens' DNA on it. But Clemens' lawyer Rusty Hardin said in his opening statement that the defense will contend that McNamee put the steroids in the needle after injecting Clemens and that the coach in fact had used the needle to inject Clemens with vitamin B12. Clemens has maintained for years that he received B12 shots and the local anesthetic lidocaine but not performance-enhancing drugs.

Prosecutor Courtney Saleski tried to pre-empt that by asking Keel if there was any way to "fake this."

Keel said no.

"If this were contrived, I would expect to obtain much more biological material," he said in other words, it would be hard to fake a sample with such a small amount of biological material on it.

Here is the original post:
Expert says DNA on medical waste allegedly saved after steroids injection matched Clemens'

Posted in DNA

Expert: DNA on medical waste matched Clemens'

(CBS/AP) WASHINGTON - A forensic scientist testified Friday that two cotton balls and a syringe needle allegedly saved after a steroids injection tested positive for Roger Clemens' DNA, a key moment as the government tries to prove the former pitcher used performance-enhancing drugs.

Alan Keel told jurors that the DNA on both cotton ball matches were "unique to one person who has ever lived on the planet" Clemens. He said that one of the cotton balls had a random match possibility of one in 15.4 trillion for Clemens' DNA, and the other had one in 173 trillion, when comparing to the population of white people in the U.S.

The needle was not as conclusive, because Keel was only able to get a handful of cells. That match was one in 449.

Brian McNamee, Clemens' former strength coach, earlier testified he collected the medical waste after injecting the pitcher with steroids in 2001, and turned them over to federal authorities in 2008. Earlier government witnesses testified that steroids were found on the medical waste.

Clemens is accused of lying to Congress in 2008 when he denied using performance-enhancing drugs.

Prosecutors hope that Clemens' DNA which helped make him one of the most successful pitchers in baseball history will help them convict him of a federal crime.

While Keel's testimony was a milestone moment for the government, the defense indicated early on it wouldn't contest that the needle had both steroids and Clemens' DNA on it. But Clemens' lawyer Rusty Hardin said in his opening statement that the defense will contend that McNamee put the steroids in the needle after injecting Clemens and that the coach in fact had used the needle to inject Clemens with vitamin B12. Clemens has maintained for years that he received B12 shots and the local anesthetic lidocaine but not performance-enhancing drugs.

Prosecutor Courtney Saleski tried to pre-empt that by asking Keel if there was any way to "fake this."

Keel said no.

"If this were contrived, I would expect to obtain much more biological material," he said in other words, it would be hard to fake a sample with such a small amount of biological material on it.

Read this article:
Expert: DNA on medical waste matched Clemens'

Posted in DNA

DNA Study Seeks Origin of Appalachia's Melungeons

For years, varied and sometimes wild claims have been made about the origins of a group of dark-skinned Appalachian residents once known derisively as the Melungeons. Some speculated they were descended from Portuguese explorers, or perhaps from Turkish slaves or Gypsies.

Now a new DNA study in the Journal of Genetic Genealogy attempts to separate truth from oral tradition and wishful thinking. The study found the truth to be somewhat less exotic: Genetic evidence shows that the families historically called Melungeons are the offspring of sub-Saharan African men and white women of northern or central European origin.

And that report, which was published in April in the peer-reviewed journal, doesn't sit comfortably with some people who claim Melungeon ancestry.

"There were a whole lot of people upset by this study," lead researcher Roberta Estes said. "They just knew they were Portuguese, or Native American."

Beginning in the early 1800s, or possibly before, the term Melungeon (meh-LUN'-jun) was applied as a slur to a group of about 40 families along the Tennessee-Virginia border. But it has since become a catch-all phrase for a number of groups of mysterious mixed-race ancestry.

In recent decades, interest in the origin of the Melungeons has risen dramatically with advances both in DNA research and in the advent of Internet resources that allow individuals to trace their ancestry without digging through dusty archives.

G. Reginald Daniel, a sociologist at the University of California-Santa Barbara who's spent more than 30 years examining multiracial people in the U.S. and wasn't part of this research, said the study is more evidence that race-mixing in the U.S. isn't a new phenomenon.

"All of us are multiracial," he said. "It is recapturing a more authentic U.S. history."

Estes and her fellow researchers theorize that the various Melungeon lines may have sprung from the unions of black and white indentured servants living in Virginia in the mid-1600s, before slavery.

They conclude that as laws were put in place to penalize the mixing of races, the various family groups could only intermarry with each other, even migrating together from Virginia through the Carolinas before settling primarily in the mountains of East Tennessee.

Link:
DNA Study Seeks Origin of Appalachia's Melungeons

Posted in DNA

Clemens’ DNA formally linked to needle

Alan Keel, a DNAforensic scientist for the prosecution, has just linked Roger ClemensDNA to some of the medical waste stored in a crumpled beerby Brian McNamee for seven years.

The medical waste is the only physical evidence linking Clemens to the baseball doping scandal.

Keel, who is still testifying, said his lab found Clemens DNA on two cotton balls and at least one needle that had been used for an anabolic steroid shot.

McNamees DNA was found on wadded gauze that had blood stains, apparently from giving an injection.

McNamee claims he gave Clemens shots of performance enhancing drugs betwen 1998 and 2001.

Clemens claims McNamee gave him shots of vitamin B-12 and the pain-killer lidocaine but never performance enhancing drugs.

Clemens is accused of lying to Congress for sworn testimony in 2008 in which he denied that he had used the banned substances.

Click SHOW CAPTION for more.

Former trainer Brian McNamee arrives at the federal court in Washington, Monday, May 14, 2012. McNamee, Roger Clemens' chief accuser, testified Monday against the former pitcher, a make-or-break moment for the prosecution as it seeks to convict Clemens of perjury. (Susan Walsh / Associated Press)

Roger Clemens arrives at federal court for his perjury and obstruction trial on May 14, 2012, in Washington, DC. (Brendan Hoffman / Getty Images)

Visit link:
Clemens’ DNA formally linked to needle

Posted in DNA

Expert: DNA on medical waste was Clemens'

Updated: May 25, 2012, 2:46 PM ET

WASHINGTON -- A forensic scientist testified Friday that two cotton balls and a syringe needle allegedly saved after a steroids injection tested positive for Roger Clemens' DNA, a key moment as the government tries to prove the former pitcher used performance-enhancing drugs.

Alan Keel told jurors that the DNA on both cotton ball matches were "unique to one person who has ever lived on the planet" -- Clemens. He said that one of the cotton balls had a random match possibility of one in 15.4 trillion for Clemens' DNA, and the other had one in 173 trillion, when comparing to the population of white people in the U.S.

The needle was not as conclusive, because Keel was only able to get a handful of cells. That match was one in 449.

As the jurors in the Roger Clemens perjury trial completed their 22nd day and listened to the 21st government witness, they were increasingly restive, demanding and skeptical, writes Lester Munson. Story

Brian McNamee, Clemens' former strength coach, earlier testified he collected the medical waste after injecting the pitcher with steroids in 2001, and turned them over to federal authorities in 2008. Earlier government witnesses testified that steroids were found on the medical waste.

Clemens is accused of lying to Congress in 2008 when he denied using performance-enhancing drugs.

Prosecutors hope that Clemens' DNA -- which helped make him one of the most successful pitchers in baseball history -- will help them convict him of a federal crime.

While Keel's testimony was a milestone moment for the government, the defense indicated early on it wouldn't contest that the needle had both steroids and Clemens' DNA on it. But Clemens' lawyer Rusty Hardin said in his opening statement that the defense will contend that McNamee put the steroids in the needle after injecting Clemens and that the coach in fact had used the needle to inject Clemens with vitamin B12. Clemens has maintained for years that he received B12 shots and the local anesthetic Lidocaine but not performance-enhancing drugs.

Prosecutor Courtney Saleski tried to pre-empt that by asking Keel if there was any way to "fake this."

Visit link:
Expert: DNA on medical waste was Clemens'

Posted in DNA

Expert: DNA on evidence matches Clemens'

Roger Clemens is on accused of lying to Congress over his alleged steroid use.

AP

WASHINGTON (AP) -- A forensic scientist testified Friday that two cotton balls and a syringe needle allegedly saved after a steroids injection tested positive for Roger Clemens' DNA, a key moment as the government tries to prove the former pitcher used performance-enhancing drugs.

Alan Keel told jurors that the DNA on both cotton ball matches were "unique to one person who has ever lived on the planet" - Clemens. He said that one of the cotton balls had a random match possibility of one in 15.4 trillion for Clemens' DNA, and the other had one in 173 trillion, when comparing to the population of white people in the U.S.

The needle was not as conclusive, because Keel was only able to get a handful of cells. That match was one in 449.

Brian McNamee, Clemens' former strength coach, earlier testified he collected the medical waste after injecting the pitcher with steroids in 2001, and turned them over to federal authorities in 2008. Earlier government witnesses testified that steroids were found on the medical waste.

Clemens is accused of lying to Congress in 2008 when he denied using performance-enhancing drugs.

Prosecutors hope that Clemens' DNA -- which helped make him one of the most successful pitchers in baseball history -- will help them convict him of a federal crime.

While Keel's testimony was a milestone moment for the government, the defense indicated early on it wouldn't contest that the needle had both steroids and Clemens' DNA on it. But Clemens' lawyer Rusty Hardin said in his opening statement that the defense will contend that McNamee put the steroids in the needle after injecting Clemens and that the coach in fact had used the needle to inject Clemens with vitamin B12. Clemens has maintained for years that he received B12 shots and the local anesthetic lidocaine but not performance-enhancing drugs.

Prosecutor Courtney Saleski tried to pre-empt that by asking Keel if there was any way to "fake this."

Continued here:
Expert: DNA on evidence matches Clemens'

Posted in DNA

Proposed biology research complex unveiled for San Pedro waterfront

After three years of development, a plan was released Thursday for a biology research complex equipped with research vessels, high-tech laboratories and a wave tank along San Pedro's waterfront.

The proposed 28-acre oceanfront campus, dubbed City Dock One Marine Research Center, would serve as the new home for the Southern California Marine Institute, a consortium of 11 college and university campuses.

If ultimately approved by the Los Angeles City Council and the Board of Harbor Commissioners, the facility would share space with government researchers, marine-related businesses and environmental groups, according to a draft environmental impact report released by port officials.

"City Dock One has the ability to be transformational to San Pedro and the Harbor Area because it brings another type of job cluster to our port and region," said Geraldine Knatz, executive director of the Port of Los Angeles, who has led the planning for the research facility and first brought her idea before the harbor commission in August 2009.

Earlier this month, the harbor commission agreed to establish a nonprofit group to raise funds to build the new lab, which is estimated to cost $416 million over two phases.

Plans call for equipping the new SCMI facility with classrooms, offices, laboratories, water storage tanks, a 150-seat auditorium with theater-style seating, and an 18,500-square-foot floating dock with a dozen slips to accommodate small

The old Westway Terminal Corp. property at Berths 70-71 would be converted into a 50,000-square-foot lab for the National Oceanic and Atmospheric Administration and berths for research vessels up to 250 feet long.

One of the facility's main attractions will be a steel-reinforced concrete wave tank that would study the rise and fall of sea levels, sea shifts and the effects of tsunamis on the Pacific Ocean.

The spacious marine campus would be an upgrade from the SCMI's current 11,000-square-foot facility on Terminal Island, said Dan Pondella, the institute's board president and an associate professor of biology at Occidental College.

"This is a completely unique project and our work on this is unlike any other marine lab we know of in the world," Pondella said. "It's a complete win-win for the surrounding communities, the harbor and the schools involved because it will be a job creator and an excellent teaching tool for students in our area."

Here is the original post:
Proposed biology research complex unveiled for San Pedro waterfront

Science magazine prize awarded to course that brings biology and math worlds closer

Public release date: 24-May-2012 [ | E-mail | Share ]

Contact: Natasha Pinol npinol@aaas.org 202-326-7088 American Association for the Advancement of Science

An undergraduate course that allows students to build mathematical models of biological phenomenaand to experience a convergence of disciplines with potential in areas ranging from cancer treatment to reforestationis the winner of the Science Prize for Inquiry-Based Instruction (IBI).

Hillel Chiel, professor of biology, neurosciences, and biomedical engineering at Case Western Reserve University, is the creator of the course. As he explains, biology students who know how to build models of biological phenomena and engineering students who can explore biological phenomena for engineering insights are better prepared to do research in their fields.

"People who have training in both are going to have an advantage," says Chiel.

Science's IBI Prize was developed to showcase outstanding materials, usable in a wide range of schools and settings, for teaching science courses at the college level. The materials must be designed to encourage students' natural curiosity about how the world works, rather than to deliver facts and principles about what scientists have already discovered. Organized as one free-standing "module," the materials should offer real understanding of the nature of science, as well as providing an experience in generating and evaluating scientific evidence. Each month, Science publishes an essay by a recipient of the award, which explains the winning project. The essay about the Dynamics of Biological Systems course, by Chiel, Jeffrey Gill, Jeffrey McManus, and Kendrick Shaw, will be published on May 25.

"We want to recognize innovators in science education, as well as the institutions that support them," says Bruce Alberts, editor-in-chief of Science. "At the same time, this competition will promote those inquiry-based laboratory modules with the most potential to benefit science students and teachers. The publication of an essay in Science on each winning module will encourage more college teachers to use these outstanding resources, thereby promoting science literacy."

A review of Chiel's background shows the protean tendency that would evolve into the interdisciplinary approach evidenced by much of his workincluding his novel designs for biologically inspired robotsand by the course module Dynamics of Biological Systems. As a child growing up on Long Island, Chiel planned to be a scientist and was fascinated by how things worked, but he was so fond of reading novels that once he was almost locked in his school library overnight.

At age 14, Chiel was given an opportunity to study calculus with physicist Alan Natapoff, which he says was "a very positive experience." When it was time for Chiel to go to college, however, he chose Yale over MIT, becoming an English major, enchanted at the thought of spending his time reading in the stacks of Yale's Sterling Memorial Library.

During the summer between Chiel's junior and senior years, he worked in the neurochemistry lab of Richard Wurtman, doing research that resulted in the publication of Chiel's first scientific paper. Chiel graduated from Yale and then went on to do a Ph.D. with Wurtman at MIT.

See the rest here:
Science magazine prize awarded to course that brings biology and math worlds closer